NCT00127803 - Safety, Tolerability, and Immunogenicity Study of a Clostridium Difficile Toxoid Vaccine in Healthy Adult Volunteers | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

January 31, 2006

Study Completion Date

March 31, 2006

Conditions

Clostridium Infections

Interventions

BIOLOGICAL

Placebo (vaccine diluent)

0.5 mL, intramuscular (IM) on Days 0, 28, and 56, respectively.

BIOLOGICAL

Clostridium difficile vaccine

0.5 mL, intramuscular on Days 0, 28, and 56, respectively.

BIOLOGICAL

Clostridium difficile vaccine

0.5 mL, intramuscular on Days 0, 28, and 56, respectively.

BIOLOGICAL

Clostridium difficile vaccine

0.5 mL, intramuscular on Days 0, 28, and 56, respectively.